IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RTW Investments, LP

Q4 2014 Holdings

Filed 2015-02-17 | 21 holdings | $60.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$33.0M340,39554.4%
Biocryst Pharmaceuticals(BCRX)COM09058V103$27.5M2,261,36145.3%
Taro Pharmaceutical Inds LTDSHSM8737E108$39.7K267,8830.1%
Dyax CorpCOM26746E103$30.0K2,131,8080.0%
Achillion Pharmaceuticals in(ACHNEUR)COM00448Q201$19.9K1,622,6330.0%
LA Jolla Pharmaceutical Co(LJPC)COM PAR $.0001 2503459604$19.6K1,064,2470.0%
Arrowhead Resh CorpCOM NEW042797209$19.3K2,610,0000.0%
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$18.4K1,115,9810.0%
ZS Pharma IncCOM98979G105$15.6K374,8210.0%
Relypsa IncCOM759531106$13.9K450,2390.0%
Xenoport IncCOM98411C100$7.4K842,5680.0%
Vanda Pharmaceuticals Inc(VNDA)COM921659108$7.2K500,0000.0%
Targacept IncCOM87611R306$7.0K2,665,6430.0%
Avalanche Biotechnologies inCOM05337G107$2.7K50,0000.0%
Repros Therapeutics IncCOM NEW76028H209$2.3K229,3640.0%
Cytrx CorpCOM PAR $.001232828509$1.9K705,0000.0%
Assembly Biosciences IncCOM045396108$1.6K204,0000.0%
Protalix Biotherapeutics IncCOM74365A101$1.6K843,8510.0%
Lipocine Inc NewCOM53630X104$1.1K209,3330.0%
Nevro Corp(NVROEUR)COM64157F103$59415,3560.0%
Lpath IncCOM NEW548910306$16960,0000.0%